Capital Fund Management (CFM)’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.1M | Buy |
154,381
+99,117
| +179% | +$3.27M | 0.01% | 377 |
|
|
2025
Q1 | $2.22M | Buy |
55,264
+14,818
| +37% | +$596K | 0.01% | 539 |
|
|
2024
Q4 | $1.9M | Buy |
40,446
+4,924
| +14% | +$232K | ﹤0.01% | 582 |
|
|
2024
Q3 | $1.88M | Sell |
35,522
-27,160
| -43% | -$1.43M | 0.01% | 524 |
|
|
2024
Q2 | $3.4M | Buy |
62,682
+47,079
| +302% | +$2.55M | 0.01% | 389 |
|
|
2024
Q1 | $1.09M | Buy |
+15,603
| New | +$1.09M | ﹤0.01% | 569 |
|
|
2017
Q2 | – | Sell |
-16,600
| Closed | -$213K | – | 829 |
|
|
2017
Q1 | $213K | Buy |
+16,600
| New | +$213K | ﹤0.01% | 791 |
|